• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

A F Enterprises Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
538351
INE663P01015
17.2626531
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
5.58
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Dr Reddy's Laboratories consolidated net profit declines 86.14% in the March 2026 quarter
May 12,2026
Net profit of Dr Reddy's Laboratories declined 86.14% to Rs 220.90 crore in the quarter ended March 2026 as against Rs 1593.30 crore during the previous quarter ended March 2025. Sales declined 11.64% to Rs 7516.20 crore in the quarter ended March 2026 as against Rs 8506.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.80% to Rs 4196.00 crore in the year ended March 2026 as against Rs 5655.10 crore during the previous year ended March 2025. Sales rose 3.19% to Rs 33593.30 crore in the year ended March 2026 as against Rs 32553.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7516.208506.00 -12 33593.3032553.50 3
OPM %5.0923.49 -19.2126.26 -
PBDT756.802459.90 -69 7451.509383.20 -21
PBT199.702005.20 -90 5392.707679.50 -30
NP220.901593.30 -86 4196.005655.10 -26